Study tracking PCA3 levels after prostate cancer surgery
Part of Cancer, Kidney & urinary clinical trials.
This study looks at changes in a marker called PCA3 in the fluid drained from the surgical site after prostate removal. It aims to help predict recovery and cancer outcomes for prostate cancer patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with prostate cancer and are scheduled for or have had surgery to remove the prostate.
- You did not receive hormone therapy or chemotherapy before your surgery.
- You do not have urine leaking from the surgical drain (the drainage fluid will be tested to check for this).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how levels of PSA in the fluid from a drainage tube after prostate removal may help predict the future course of prostate cancer. It may offer insights into recovery and next steps.
This study looks at a test done on the fluid from your surgical drain after prostate removal. It aims to see if changes in that test over time can help predict how well you recover.
This trial studies whether testosterone levels before and around radical prostate surgery affect cancer control and sexual/physical recovery. It may help doctors understand who benefits from testosterone replacement and who should not.
This study looks at how PSA (a blood marker) levels measured shortly after prostate removal surgery can predict whether cancer comes back. Researchers hope this helps doctors identify patients who may need closer monitoring or additional treatment after surgery.
This trial tests a new way to find microscopic cancer cells (minimal residual disease) in the blood after prostate surgery. If successful, it could help doctors decide if additional treatment is needed.
This study looks at patients who have had a prostate biopsy or surgery to remove the prostate (radical prostatectomy). It aims to learn more about these procedures and how patients are doing.
Hear when a new Prostatic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.